RevBio Teams with NIH for Groundbreaking Clinical Trial Grant
RevBio Secures $2.4 Million Grant for Clinical Innovation
Lowell, Massachusetts – RevBio, Inc. proudly announces that it has received a significant $2.4 million grant from the National Institutes of Health (NIH) to support its innovative regenerative bone adhesive, TETRANITE. This milestone grant is part of the Phase II Small Business Innovation Research (SBIR) initiative designed to accelerate advancements in medical technology.
Understanding TETRANITE
TETRANITE is a cutting-edge injectable bone adhesive intended for use in various surgical applications, particularly to enhance stabilization during brain surgery procedures. The awarded funding will facilitate a comprehensive clinical trial focusing on the safety and effectiveness of this unique biomaterial, specifically for cranial flap fixation.
Clinical Trial Insights
This clinical trial, already approved by the FDA, is set to involve 20 patients, with five enrolled so far. The study is being conducted at prominent institutions, including the Semmes Murphey Clinic and Brigham and Women’s Hospital. Initial feedback has been encouraging, with signs of effective healing reported in early participants.
The Role of TETRANITE in Surgery
Dr. L. Madison Michael, a prominent neurosurgeon participating in the trial, has expressed optimism about the early outcomes. According to Dr. Michael, the healing process has been notably positive, with radiographic imaging confirming the secure adhesion of bone flaps to the skull. This breakthrough could pave the way for a shift in surgical practices regarding cranial surgeries.
The Benefits of Improved Bone Adhesives
Modern surgical techniques, combined with advancements like TETRANITE, are enhancing patient recovery experiences significantly. Dr. Timothy R. Smith emphasizes that robust healing solutions like TETRANITE not only help physically but also boost patients' emotional well-being following major surgeries.
RevBio’s Vision and Future Prospects
Founded with a mission to enhance surgical outcomes, RevBio is focused on innovative medical solutions that can transform patient care. TETRANITE represents just one facet of the company’s wider objectives, investing heavily in research to expand into other markets such as dentistry and orthopedics.
About RevBio, Inc.
RevBio, Inc. stands at the forefront of medical device development, primarily focusing on pioneering synthetic biomaterials. TETRANITE is designed to be self-setting and osteoconductive, amplifying its use within the healthcare landscape. As a clinical stage company, RevBio is committed to ensuring that its groundbreaking technologies receive the necessary approvals for safe and effective commercial use.
Frequently Asked Questions
What is TETRANITE, and how does it work?
TETRANITE is a synthetic, injectable bone adhesive designed for surgical applications, specifically for cranial flap fixation.
How much funding has RevBio received for the clinical trial?
RevBio has secured a $2.4 million grant from the NIH to support its clinical trial.
Where is the clinical trial being conducted?
The clinical trial is taking place at the Semmes Murphey Clinic and Brigham and Women’s Hospital.
Has the clinical trial received any approvals?
Yes, the clinical trial has been approved by the FDA.
What other markets does RevBio plan to enter?
RevBio is exploring applications in dentistry, orthopedics, and animal health markets.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- SoftBank and Intelsat Collaborate for Global Connectivity Future
- Forge Expands Strategic Partnerships with Gaming Innovators
- Plug and Play Partners with Cathay for Digital Innovation
- Important Investor Insights for lululemon Securities Owners
- Legal Update: Actions for Shareholders of Super Micro Computer
- Record Viewership for Emmy Awards Brings New Hope to Television
- Microsoft Boosts Shareholder Value with Dividend Increase and Buyback
- Rob Gronkowski's Market Insights: A New Perspective for Investors
- Teamsun Entities Divest Significant Stakes in Grid Dynamics
- Edwards Lifesciences Expands Options with SAPIEN 3 Launch
Recent Articles
- Challenges for Outset Medical: Examining Recent Drops in Shares
- Sibanye-Stillwater Faces Investigation Following Data Breach
- CVG to Showcase Insights During Upcoming Virtual Investor Conference
- Investors Raise Concerns as Super Micro Computer Faces Legal Issues
- Politan Capital Advocates for Independent Board Changes at Masimo
- The RealReal Leaders Set for Wells Fargo Consumer Conference
- Indivior PLC Shareholders Urged to Act Before Deadline
- Deadline Approaches for Vicor Corporation Securities Action
- Lunchly Launch: MrBeast, Logan Paul, and KSI Challenge Lunchables
- Matt Hull Brings AI Expertise to Sabio Holdings Board
- Investors Urged to Consider Class Action Against Spire Global
- Labcorp's Recent Senior Notes Offering Signals Growth Ahead
- Data Storage Corp Executive Stock Plans and Business Updates
- TLGY Acquisition Corp Announces Merger Extension Plans
- Walker & Dunlop Strengthens Partnership with JPMorgan Chase
- 5E Advanced Materials Pursues Strategic Financing Agreement
- Ashland Inc. Updates Receivables Purchase Agreement Terms
- iCoreConnect Inc. Faces Challenges Amid Special Meeting Delay
- Roivant Sciences Holds Annual Meeting, Directors and Auditors Approved
- EnLink Midstream's Strategic Shift: Credit Amendments and Future Plans
- Banzai International Implements Strategic Reverse Stock Split
- Augmedix Provides Update on Strategic Merger Developments
- Microsoft Unveils New $60 Billion Share Buyback Initiative
- CVG Leaders to Present at Upcoming Small-Cap Investor Event
- IDEX Biometrics Closes NOK 70 Million Private Placement Successfully
- InnovAge Partners for Study on Senior Fall Prevention Strategies
- The RealReal's Upcoming Participation in Major Conference
- Investigation Launched into Data Breach at David's Bridal
- Natura Resources Achieves Milestone with Historic NRC Permit
- Great Elm Group Welcomes Deloitte as New Auditor for Future Growth
- AgriForce Secures New Funding Agreement, Adjusts Executive Pay
- Brainstorm Cell Therapeutics Shares Incentive Plan Enhancements
- CareMax Secures Waiver Extension Amid Financial Restructuring
- Equity Bancshares Declares Quarterly Cash Dividend for Shareholders
- InPoint Commercial Real Estate's Recent NAV Update and Insights
- Owens & Minor Completes Redemption of Senior Notes Successfully
- OpenAI Establishes Independent Safety Committee for AI Oversight
- Héroux-Devtek's Strategic Acquisition by Platinum Equity Approved
- Kilroy Realty Announces Dividend Plans for Shareholders
- Nvidia's Impact on Market Drives Unprecedented Wealth Growth
- Lead the Fight: Taro Pharmaceutical Investors Can Act Now
- Investigation into Customers Bancorp Following Compliance Issues
- Franklin Resources Faces Challenges Amid Leadership Shakeup
- Kemper Sports Management Data Breach Investigation Update
- Cardlytics Faces Investor Concerns Amid Growth Challenges
- EDXM Global Set to Revolutionize Crypto Trading with New Venue
- Ibotta (IBTA) Faces Challenges Following Lackluster Quarterly Report
- Ford Motor Company Investors Should Act Before Lead Deadline
- iLearningEngines Takes Action Amid Revenue Scrutiny Concerns
- How Intel Lost the PlayStation 6 Chip Contract to AMD